Biomotion Sciences Company Leadership
| SLXN Stock | 2.47 0.10 3.89% |
Biomotion Sciences employs about 11 people. The company is managed by 4 executives with a total tenure of roughly 26 years, averaging almost 6.0 years of service per executive, having 2.75 employees per reported executive. Analysis of Biomotion Sciences' management performance can provide insight into the firm performance.
Biomotion | Build AI portfolio with Biomotion Stock |
Biomotion Sciences Management Team Effectiveness
The company has return on total asset (ROA) of (1.9354) % which means that it has lost $1.9354 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1666) %, meaning that it created substantial loss on money invested by shareholders. Biomotion Sciences' management efficiency ratios could be used to measure how well Biomotion Sciences manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Biomotion Sciences' Return On Tangible Assets are very stable compared to the past year. As of the 21st of November 2025, Return On Capital Employed is likely to grow to 20.00, though Return On Equity is likely to grow to (3.93). At this time, Biomotion Sciences' Net Tangible Assets are very stable compared to the past year. As of the 21st of November 2025, Other Current Assets is likely to grow to about 1.1 M, while Total Assets are likely to drop about 2.7 M.As of the 21st of November 2025, Common Stock Shares Outstanding is likely to grow to about 9.1 M, while Net Loss is likely to drop (886.4 K).
Biomotion Sciences Workforce Comparison
Biomotion Sciences Ordinary is rated fourth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 107. Biomotion Sciences retains roughly 11.0 in number of employees claiming about 10% of equities under Health Care industry.
Biomotion Sciences Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biomotion Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biomotion Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Biomotion Sciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Peled Amnon over a week ago Insider Trading | ||
Peled Amnon over six months ago Insider Trading |
Biomotion Sciences Notable Stakeholders
A Biomotion Sciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biomotion Sciences often face trade-offs trying to please all of them. Biomotion Sciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biomotion Sciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Ilan MBA | Chairman CEO | Profile | |
| Pr MD | Chairman CoFounder | Profile | |
| Mitchell MBA | Chief Officer | Profile | |
| Mirit Hadar | Exec Affairs | Profile |
About Biomotion Sciences Management Performance
The success or failure of an entity such as Biomotion Sciences often depends on how effective the management is. Biomotion Sciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biomotion management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biomotion management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 5.77 | 6.05 | |
| Return On Capital Employed | 19.05 | 20.00 | |
| Return On Assets | 5.77 | 6.05 | |
| Return On Equity | (4.14) | (3.93) |
Biomotion Sciences Workforce Analysis
Traditionally, organizations such as Biomotion Sciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biomotion Sciences within its industry.Biomotion Sciences Manpower Efficiency
Return on Biomotion Sciences Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.5M | |
| Net Loss Per Executive | 4.1M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Biomotion Sciences Ordinary. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in national income and product accounts. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomotion Sciences. If investors know Biomotion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomotion Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biomotion Sciences is measured differently than its book value, which is the value of Biomotion that is recorded on the company's balance sheet. Investors also form their own opinion of Biomotion Sciences' value that differs from its market value or its book value, called intrinsic value, which is Biomotion Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomotion Sciences' market value can be influenced by many factors that don't directly affect Biomotion Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomotion Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomotion Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomotion Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.